BYRN

Byrna Technologies Inc. (BYRN) - Q3 2025 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended August 31, 2025, and the nine months ended on that date. Byrna Technologies Inc. designs, manufactures, and distributes less-lethal self-defense products, including launchers and ammunition, primarily for consumer and law enforcement markets. The company operates manufacturing facilities in Fort Wayne, Indiana, and Pretoria, South Africa (which ceased operations in Q3 2025). The company is classified as a non-accelerated filer and a smaller reporting company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 35.1% in Q3 and 43.4% YTD compared to the prior year. Growth was driven by a shift in marketing strategy toward celebrity endorsers, a 155% increase in domestic wholesale sales (Q3), and new royalty revenue from the LATAM Licensing Agreement.
• Margin Compression: Gross margin decreased slightly (60.1% vs 62.4% in Q3) due to a higher mix of wholesale sales, which carry lower margins than direct-to-consumer e-commerce sales.
• Working Capital Strain: Despite profitability, operating cash flow turned negative ($11.5 million used YTD) due to significant increases in inventory ($14.1 million increase) and accounts receivable ($6.2 million increase) to support sales growth.
• Asset Base: Inventory nearly doubled from $20.0 million to $34.1 million. Property and equipment increased significantly due to capital expenditures for new retail stores and an ammunition manufacturing facility.
• South Africa Operations: The manufacturing facility in Pretoria ceased operations in Q3 2025.

Guidance, Outlook, and Risks

• Capital Strategy: The company has a $10 million stock buyback program approved in July 2024. As of August 31, 2025, $3.8 million has been utilized. No shares were repurchased in Q3 2025.
• Liquidity: Management intends to fund operations from funds raised through operations over the next 12 months but may pursue secondary equity offerings or debt financing if necessary. Cash balances decreased by $10.3 million during the nine-month period.
• Tax Impact: The company recorded income tax expense of $1.7 million YTD (effective rate 18.3%) following the enactment of the "One Big Beautiful Bill Act" (OBBBA) on July 4, 2025, which impacts R&D expenses and bonus depreciation.
• Risk Factors: Key risks include exposure to tariffs and trade barriers (specifically regarding imports from China), foreign currency fluctuations (South African Rand), and the ability to manage supply chain and production delays. The company is not using forward contracts to hedge currency risk.

Investor Verification Checklist

• Inventory Turnover: Verify the sell-through rate of the $34.1 million inventory balance to ensure it does not become obsolete or require significant write-downs.
• Cash Burn vs. Profitability: Monitor the divergence between GAAP net income and negative operating cash flow; confirm if the cash outflow is temporary due to strategic stockpiling or indicative of collection issues.
• Wholesale Channel Mix: Assess the long-term impact of the shift toward wholesale channels on overall gross margins and customer concentration risk.
• Capital Expenditures: Confirm the timeline and ROI for the new ammunition manufacturing facility and retail store build-outs driving recent CapEx.
• Tax Rate Volatility: Review the specific impact of the OBBBA on future effective tax rates and deferred tax asset valuations.